Men's Health News

RSS

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Mitomics, world leader in the research and development of mitochondrial genome-based products, today announced it has entered into a non-exclusive licensing agreement with QDx Pathology Services to develop, market and process the QPredict™ Prostate Mitomic Test.

19 May 2011

Treadmill test helps predict lifetime risk of cardiovascular disease in middle-age people

In two separate studies, UT Southwestern Medical Center researchers have found that how fast a middle-age person can run a mile can help predict the risk of dying of heart attack or stroke decades later for men and could be an early indicator of cardiovascular disease for women.

19 May 2011

Silodosin helps reduce chronic prostatitis in men

New findings show that treatment with a specific alpha blocker helps reduce symptoms and improve quality of life for men with chronic prostatitis/chronic pelvic pain syndrome.

18 May 2011

New denosumab Phase III trial data in high-risk prostate cancer presented at AUA conference

Data on the use of denosumab (Xgeva) to improve bone metastases-free survival in men with high-risk prostate cancer was presented at the American Urological Association conference today for the first time.

18 May 2011

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

Amgen today announced primary results of a pivotal Phase 3 trial demonstrating that XGEVA significantly increased bone metastasis-free survival for more than four months in men with castrate-resistant metastatic prostate cancer that has not yet spread to bone.

18 May 2011

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C.

18 May 2011

Coffee reduces prostate cancer risk

In the 20-year study of almost 50,000 men, researchers noted that those who drank at least six cups a day were 20 per cent less likely to get prostate cancer than those who never took coffee. Strikingly, they were 60 per cent less likely than the non-coffee drinkers to die of the disease. The researchers also say that decaffeinated coffee is just as effective.

17 May 2011

Uganda launches PEPFAR-supported mobile male circumcision clinic

U.S. Ambassador to Uganda Jerry Lanier on Friday in Kampala launched a Mobile Medical Male Circumcision clinic, a project of the PEPFAR-supported Makerere University Walter Reed Project, New Vision reports.

17 May 2011

New A+PSA assay more accurately detects prostate cancer

A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

17 May 2011

UW's ultrathin laser endoscope gives a Google Earth view of the bladder

Bladder cancer is the fourth-most-common cancer in men and one of the most expensive cancers to treat from diagnosis to death. After initial diagnosis and surgery, patients must return to the urologist at least yearly for a costly, time-consuming and uncomfortable bladder scan. Tumors recur in more than half of patients.

17 May 2011

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

Researchers have linked a variant in the vitamin D receptor gene (VDR) with the onset of chronic obstructive pulmonary disease (COPD) in Caucasian men. The study population consisted of participants in the Veterans Administration Normative Aging Study, a multidisciplinary study of aging that began in 1963.

16 May 2011

Insight into male infertility

Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.

16 May 2011

Obese men may face high risk of prostate cancer progression

Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.

16 May 2011

Stress related to pregnancy affects health of expectant parents and their infants

A University of Missouri researcher has found that stress related to pregnancy uniquely affects the health of expectant fathers, which in turn, influences the health of expectant mothers and their infants.

13 May 2011

New circumcision treatment can reduce HIV

Promising study results published in the May issue of JAIDS show that a novel medical device has the potential to revolutionize how male circumcision services are offered in countries hardest hit by the HIV epidemic.

13 May 2011

Groundbreaking cancer treatment studies to be unveiled at AAPS National Biotechnology Conference

Cancer studies from Mercer University headline groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC).

13 May 2011

Prostrate cancer patients can benefit from new MRI-ultrasound fusion

Targeted biopsy, a major advance in prostate cancer diagnostics, was detailed by a UCLA team in the current issue of Urologic Oncology. The new technology fuses MRI with real-time 3D ultrasound, providing an exacting method to obtain biopsy specimens from suspicious areas in the prostate.

12 May 2011

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer

Cancer researchers are a step closer to finding a cure for advanced prostate cancer after effectively combining an anti-cancer drug with a viral gene therapy in vivo using novel ultrasound-targeted microbubble-destruction (UTMD) technology.

11 May 2011

Researchers discover role of MAN2C1 protein in prostate cancer development

It's a disease affecting those closest to us - our fathers, brothers and sons. Prostate cancer impacts one in six men in Canada. Last year, roughly 24,600 men were diagnosed with the disease.

11 May 2011

Surgery reduces mortality risk of prostate cancer

A Swedish research team partly consisting of researchers from Uppsala University followed a group of prostate cancer patients in the Nordic region for 15 years. The study found, among other things, that surgery reduces the risk that men with prostate cancer (even those with low-risk tumours) will die within 15 years. The results were published today in the New England Journal of Medicine.

6 May 2011

Men's Health News

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Treadmill test helps predict lifetime risk of cardiovascular disease in middle-age people

Silodosin helps reduce chronic prostatitis in men

New denosumab Phase III trial data in high-risk prostate cancer presented at AUA conference

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

Coffee reduces prostate cancer risk

Uganda launches PEPFAR-supported mobile male circumcision clinic

New A+PSA assay more accurately detects prostate cancer

UW's ultrathin laser endoscope gives a Google Earth view of the bladder

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

Insight into male infertility

Obese men may face high risk of prostate cancer progression

Stress related to pregnancy affects health of expectant parents and their infants

New circumcision treatment can reduce HIV

Groundbreaking cancer treatment studies to be unveiled at AAPS National Biotechnology Conference

Prostrate cancer patients can benefit from new MRI-ultrasound fusion

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer

Researchers discover role of MAN2C1 protein in prostate cancer development

Surgery reduces mortality risk of prostate cancer

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News